Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Marrow”

5,837 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,837 results

Early research (Phase 1)Ended earlyNCT02641002
What this trial is testing

CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Celgene 28
Testing effectiveness (Phase 2)Study completedNCT00002619
What this trial is testing

Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Glioblastoma Multiforme or Brain Stem Tumors

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health 60
Not applicableEnded earlyNCT05611307
What this trial is testing

Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

Who this might be right for
Testicular CancerSurvivorshipASCVD+5 more
Indiana University 31
Testing effectiveness (Phase 2)Looking for participantsNCT05027945
What this trial is testing

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Who this might be right for
ImmunodeficiencyHematopoietic Stem Cell Transplantation
National Cancer Institute (NCI) 54
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Not applicableStudy completedNCT03161665
What this trial is testing

Patient and Caregiver Participation Through an Educational Health Information Technology System ("BMT Roadmap") in the Context of Hematopoietic Cell Transplantation

Who this might be right for
Patients Undergoing Bone Marrow Transplant (BMT)
University of Michigan Rogel Cancer Center 40
Not applicableStudy completedNCT00038675
What this trial is testing

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myeloid LeukemiaPolycythemia Vera+2 more
M.D. Anderson Cancer Center 125
Not applicableStudy completedNCT06851065
What this trial is testing

Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Patients With Lower-Risk Myelodysplastic Syndromes in the United States

Who this might be right for
Myelodysplastic Syndromes
Bristol-Myers Squibb 418
Testing effectiveness (Phase 2)Study completedNCT00054431
What this trial is testing

Imatinib Mesylate and Decitabine in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Chronic Myelogenous Leukemia+2 more
National Cancer Institute (NCI) 80
Early research (Phase 1)Looking for participantsNCT05367700
What this trial is testing

HS-10382 in Patients With Chronic Myeloid Leukemia.

Who this might be right for
CML, Chronic PhaseCML, Accelerated Phase
Jiangsu Hansoh Pharmaceutical Co., Ltd. 108
Testing effectiveness (Phase 2)Looking for participantsNCT06345495
What this trial is testing

High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly

Who this might be right for
SplenomegalyMyelofibrosis
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT00443339
What this trial is testing

Darbepoetin Alpha in Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 99
Not applicableStudy completedNCT01904175
What this trial is testing

Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant

Who this might be right for
Hodgkin's DiseaseNon Hodgkin's LymphomaMyeloma+2 more
Duke University 48
Testing effectiveness (Phase 2)Looking for participantsNCT04996875
What this trial is testing

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Who this might be right for
Advanced Systemic Mastocytosis (AdvSM)SM With an Associated Hematologic Neoplasm (SM-AHN)Mast Cell Leukemia (MCL)+1 more
Cogent Biosciences, Inc. 140
Testing effectiveness (Phase 2)Study completedNCT00895934
What this trial is testing

Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+11 more
National Cancer Institute (NCI) 52
Early research (Phase 1)Looking for participantsNCT05292664
What this trial is testing

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Who this might be right for
Myelodysplastic Syndromes, de NovoMyelodysplastic Syndromes, SecondaryMyelodysplastic Syndromes, Previously Treated+8 more
Andrew E. Place, MD 30
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Not Yet RecruitingNCT07254793
What this trial is testing

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Who this might be right for
Acute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more
University of Arizona 94
Not applicableStudy completedNCT05570643
What this trial is testing

The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor Cells

Who this might be right for
Sepsis, Endotoxemia, Immunosuppression
Radboud University Medical Center 12
Not applicableUnknownNCT04150471
What this trial is testing

Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients

Who this might be right for
Chronic Myelocytic Leukemia
Seoul St. Mary's Hospital 79
Load More Results